Last reviewed · How we verify

NCT05945069

Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects with Dry Eye Disease

Completed NA Last updated 10 March 2025
What this trial tests

NA trial testing TriLift device in Eyelid Diseases in 30 participants. Completed in 5 September 2024.

Timeline
1 August 2023
Primary endpoint
5 September 2024
5 September 2024

Quick facts

Lead sponsorLumenis Be Ltd.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 August 2023
Primary completion5 September 2024
Estimated completion5 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Lumenis Be Ltd. — full company profile →

Who can join

22 and older, any sex, with Eyelid Diseases or Eyelid Movement Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To demonstrate that DMSt + RF improves eye blink quality in subjects with dry eye disease

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Dynamic Muscle Stimulation of the Periorbital Area for Improvement of Blinking in Dry Eye Patients.
    Chelnis JG, Chelnis A. · · 2025 · cited 1× · PMID 40166689 · DOI 10.2147/opth.s513989

Verify or expand the search:

Other recruiting trials for Eyelid Diseases

Currently open trials in the same condition.

Other Lumenis Be Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05945069.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing